When planning care for a client at risk for pulmonary embolism the nurse should make which intervention a priority?

Try the new Google Books

Check out the new look and enjoy easier access to your favorite features

1. Knight M, Kenyon S, Brocklehurst P, et al. Eds.. on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care - Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–12. Oxford, University of Oxford, 2014. [Google Scholar]

2. Nelson-Piercy C, MacCallum P, Mackillop L Green-top Guideline No. 37a - reducing the risk of venous thromboembolism during pregnancy and the puerperium. London, Royal College of Obstetricians and Gynaecologists, 2015. [Google Scholar]

3. Chan WS, Ray JG, Murray S, et al.. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med 2002; 162: 1170–1175. [PubMed] [Google Scholar]

4. Shahir K, Goodman LR, Tali A, et al.. Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning. AJR Am J Roentgenol 2010; 195: W214–W220. [PubMed] [Google Scholar]

5. Ramsay R, Byrd L, Tower C, et al.. The problem of pulmonary embolism diagnosis in pregnancy. Br J Haematol 2015; 170: 727–728. [PubMed] [Google Scholar]

6. Greer I, Thomson AJ Green-top Guideline No. 37b - thromboembolic disease in pregnancy and the puerperium: acute management. London, Royal College of Obstetricians and Gynaecologists, 2015. [Google Scholar]

7. Bates SM, Greer IA, Middeldorp S, et al.. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: Suppl, 2 e691S–e736S. [PMC free article] [PubMed] [Google Scholar]

8. Knight M, Ukoss. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG 2008; 115: 453–461. [PubMed] [Google Scholar]

9. Andersen BS, Steffensen FH, Sorensen HT, et al.. The cumulative incidence of venous thromboembolism during pregnancy and puerperium–an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998; 77: 170–173. [PubMed] [Google Scholar]

10. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al.. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933–938. [PubMed] [Google Scholar]

11. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: 23 Suppl 1, I4–I8. [PubMed] [Google Scholar]

12. Bourjeily G, Paidas M, Khalil H, et al.. Pulmonary embolism in pregnancy. Lancet 2010; 375: 500–512. [PubMed] [Google Scholar]

13. Gherman RB, Goodwin TM, Leung B, et al.. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999; 94: 730–734. [PubMed] [Google Scholar]

14. James AH, Jamison MG, Brancazio LR, et al.. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194: 1311–1315. [PubMed] [Google Scholar]

15. Greer IA. Thrombosis in pregnancy: updates in diagnosis and management. Hematology (Am Soc Hematol Educ Program) 2012; 2012: 203–207. [PubMed] [Google Scholar]

16. Kamel H, Navi BB, Sriram N, et al.. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 2014; 370: 1307–1315. [PMC free article] [PubMed] [Google Scholar]

17. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. Am J Obstet Gynecol 2008; 198: 233 e1–e7. [PubMed] [Google Scholar]

18. Nelson-Piercy C. Handbook of Obstetric Medicine. 4th Edn. London, Informa UK Ltd, 2010. [Google Scholar]

19. Carson JL, Kelley MA, Duff A, et al.. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240–1245. [PubMed] [Google Scholar]

20. Rutherford SE, Phelan JP. Deep venous thrombosis and pulmonary embolism in pregnancy. Obstet Gynecol Clin North Am 1991; 18: 345–370. [PubMed] [Google Scholar]

21. Bates SM, Jaeschke R, Stevens SM, et al.. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: 2 Suppl, e351S–e418S. [PMC free article] [PubMed] [Google Scholar]

22. Khalafallah AA, Morse M, Al-Barzan AM, et al.. D-Dimer levels at different stages of pregnancy in Australian women: a single centre study using two different immunoturbidimetric assays. Thromb Res 2012; 130: e171–e177. [PubMed] [Google Scholar]

23. To MS, Hunt BJ, Nelson-Piercy C. A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy. J Obstet Gynaecol Res 2008; 28: 222–223. [PubMed] [Google Scholar]

24. Wells PS, Anderson DR, Rodger M, et al.. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001; 135: 98–107. [PubMed] [Google Scholar]

25. Righini M, Jobic C, Boehlen F, et al.. Predicting deep venous thrombosis in pregnancy: external validation of the LEFT clinical prediction rule. Haematologica 2013; 98: 545–548. [PMC free article] [PubMed] [Google Scholar]

26. Rodger MA, Le Gal G, Wells P, et al.. Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities. Thromb Res 2014; 134: 763–768. [PubMed] [Google Scholar]

27. Blanco-Molina A, Rota LL, Di Micco P, et al.. Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb Haemost 2010; 103: 306–311. [PubMed] [Google Scholar]

28. Fidler JL, Patz EF Jr, Ravin CE. Cardiopulmonary complications of pregnancy: radiographic findings. AJR Am J Roentgenol 1993; 161: 937–942. [PubMed] [Google Scholar]

29. Daftary A, Gregory M, Daftary A, et al.. Chest radiograph as a triage tool in the imaging-based diagnosis of pulmonary embolism. AJR Am J Roentgenol 2005; 185: 132–134. [PubMed] [Google Scholar]

30. Eskandar OS, Eckford SD, Watkinson T.. Safety of diagnostic imaging in pregnancy. Part 1: X-ray, nuclear medicine investigations, computed tomography and contrast media. Obstet Gynaecol 2010; 12: 71–78. [Google Scholar]

31. Remy-Jardin M, Remy J. Spiral CT angiography of the pulmonary circulation. Radiology 1999; 212: 615–636. [PubMed] [Google Scholar]

32. Hurwitz LM, Yoshizumi TT, Goodman PC, et al.. Radiation dose savings for adult pulmonary embolus 64-MDCT using bismuth breast shields, lower peak kilovoltage, and automatic tube current modulation. AJR Am J Roentgenol 2009; 192: 244–253. [PubMed] [Google Scholar]

33. Schembri GP, Miller AE, Smart R. Radiation dosimetry and safety issues in the investigation of pulmonary embolism. Semin Nucl Med 2010; 40: 442–454. [PubMed] [Google Scholar]

34. Bourjeily G, Chalhoub M, Phornphutkul C, et al.. Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero. Radiology 2010; 256: 744–750. [PubMed] [Google Scholar]

35. Scarsbrook AF, Evans AL, Owen AR, et al.. Diagnosis of suspected venous thromboembolic disease in pregnancy. Clin Radiol 2006; 61: 1–12. [PubMed] [Google Scholar]

36. Ridge CA, McDermott S, Freyne BJ, et al.. Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy. AJR Am J Roentgenol 2009; 193: 1223–1227. [PubMed] [Google Scholar]

37. Gould MK, Dembitzer AD, Doyle RL, et al.. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999; 130: 800–809. [PubMed] [Google Scholar]

38. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 2004; 140: 175–183. [PubMed] [Google Scholar]

39. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401–407. [PubMed] [Google Scholar]

40. Hirsh J, Warkentin TE, Shaughnessy SG, et al.. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119: 1 Suppl, 64S–94S. [PubMed] [Google Scholar]

41. Patel JP, Green B, Patel RK, et al.. Population pharmacokinetics of enoxaparin during the antenatal period. Circulation 2013; 128: 1462–1469. [PubMed] [Google Scholar]

42. Kahn SR, Shapiro S, Wells PS, et al.. SOX trial investigators. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 2014; 383: 880–888. [PubMed] [Google Scholar]

43. Limmer JS, Grotegut CA, Thames E, et al.. Postpartum wound and bleeding complications in women who received peripartum anticoagulation. Thromb Res 2013; 132: e19–e23. [PubMed] [Google Scholar]

Page 2

Risk factors for VTE in pregnancy